The Current Ratio of Hanall Biopharma Co Ltd (009420.KS) is 2.46.
Current Ratio compares a firm's current assets to its current liabilities to assess short-term liquidity. A ratio above 1.0 typically indicates a strong ability to meet obligations.
| Date | Value |
|---|---|
| 2024-12-31 | 2.46 |
| 2023-12-31 | 3.02 |
| 2022-12-31 | 3.92 |
| 2021-12-31 | 5.37 |
| 2020-12-31 | 5.61 |
| 2019-12-31 | 4.90 |
| 2018-12-31 | 5.89 |
| 2017-12-31 | 2.62 |
| 2016-12-31 | 6.70 |
| 2015-12-31 | 6.59 |